Clinical Trial Update: Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing azacitidine plus pevonedistat versus azacitidine in patients with acute myeloid leukemia not eligible for standard chemo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Azacitidine (Vidaza) (azacitidine)
• Pevonedistat (pevonedistat)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Leukemia, Myeloid, Acute | Phase 3 | Status: ACTIVE_NOT_RECRUITING